NCT06034938 DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road) Status RECRUITING Phase PHASE2
NCT06030037 Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/ Refractory (R/R) Melanoma Status WITHDRAWN Phase PHASE2
NCT06028633 Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients Status NOT_YET_RECRUITING Phase PHASE2
NCT06027268 Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06022757 Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19) Status TERMINATED Phase PHASE1/PHASE2
NCT06016920 Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma Status RECRUITING Phase PHASE1/PHASE2
NCT06008756 Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06004336 A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs) Status RECRUITING Phase PHASE2
NCT06001658 Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers Status RECRUITING Phase PHASE2
NCT06001320 De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05998447 GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer Status TERMINATED Phase PHASE2
NCT05977907 Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN). Status RECRUITING Phase PHASE2
NCT05958186 A Study of Cytomegalovirus Disease Epidemiology in Pediatric and Adult Liver Transplant Recipients in China Status COMPLETED Phase N/A
NCT05957081 Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309 Status RECRUITING Phase PHASE1
NCT05956041 Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas Status RECRUITING Phase PHASE2
NCT05953740 A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001) Status COMPLETED Phase PHASE1
NCT05952869 A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH) Status COMPLETED Phase PHASE3
NCT05952856 A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids Status COMPLETED Phase PHASE3